July - August 2024 | Pulmonology

Advanced Search

Share

July - August 2024

Pulmonology

Pulmonology

ISSN: 2531-0437

Pulmonology (previously Revista Portuguesa de Pneumologia) is the official journal of the Portuguese Society of Pulmonology (Sociedade Portuguesa de Pneumologia/SPP). The journal publishes 6 issues per year, mainly about respiratory system diseases in adults and clinical research. This work can range from peer-reviewed original articles to review articles, editorials, and opinion articles. The journal is printed in English, and is freely available in its web page as well as in Medline and other databases.

Pulmonology has ceased to be published by Elsevier and is now published by Taylor & Francis available here.

See more

Pulmonology has ceased to be published by Elsevier and is now published by Taylor & Francis available here.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2023

10.4

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2023

14.3

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2023

1.284

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2023

1.534

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

portada-S2531043724X00045

Vol. 30. Issue 4.

Pages 319-412 (July - August 2024)

Editorial

Physiotherapists in intensive care units: Where are we?

F. Ramalho, A. Oliveira, A. Machado, V. Azevedo, M.R. Gonçalves, G. Ntoumenopoulos, A. Marques

Pulmonol. 2024;30:319-23

Full text access

Share

Commentary

Are we overlooking the lung function in the definition of severe asthma remission?

S. Nolasco, R. Campisi, N. Crimi, C. Crimi

Pulmonol. 2024;30:324-6

Full text access

Share

Call of action

Comparison of thoracic surgery training in the Iberian Peninsula: A call for European uniformity

Álvaro Fuentes-Martín, Luís Lourenço Graça

Pulmonol. 2024;30:327-9

Full text access

Share

Original articles

Original articles

Tb

Diagnostic role of internal mammary lymph node involvement in tuberculous pleurisy: a multicenter study

G. Levi, C. Rocchetti, F. Mei, G.M. Stella, S. Lettieri, F. Lococo, F. Taccari, C. Seguiti, ... G.P. Marchetti

Pulmonol. 2024;30:330-6

Full text access

Share

Nontuberculous Mycobacteria in Portugal: Trends from the last decade

A. Santos, S. Carneiro, A. Silva, J.P. Gomes, R. Macedo

Pulmonol. 2024;30:337-43

Full text access

Share

Original articles

Asthma

Reproducibility, validity, and reliability of the incremental step test for subjects with moderate to severe asthma

R.C.C. Barbosa, R.A. Silva, A.C. Lunardi, S.T.C. Silva, S.D. Corso, A.J. Fonseca, R. Stelmach, C.R.F. Carvalho

Pulmonol. 2024;30:344-51

Full text access

Share

Original articles

Lung cancer

Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors

M. Serino, C. Freitas, M. Martins, P. Ferreira, C. Cardoso, F. Veiga, V. Santos, D. Araújo, ... V. Hespanhol

Pulmonol. 2024;30:352-61

Full text access

Share

Original articles

Pulmonary vascular disease

Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, double-blind, cross-over trial

M. Lichtblau, S. Saxer, J. Müller, P. Appenzeller, C. Berlier, S.R. Schneider, L. Mayer, M. Furian, ... S. Ulrich

Pulmonol. 2024;30:362-9

Full text access

Share

Original articles

Occupational diseases

Clinical usefulness of serum angiotensin converting enzyme in silicosis

J. Blanco-Pérez, Á. Salgado-Barreira, S. Blanco-Dorado, M.E. González Bello, A.C. Caldera Díaz, A. Pérez-Gonzalez, A. Pallarés Sanmartín, A. Fernández Villar, F.J. Gonzalez-Barcala

Pulmonol. 2024;30:370-7

Full text access

Share

Review

Issue 2 - “Update on adverse respiratory effects of indoor air pollution” Part 1): Indoor air pollution and respiratory diseases: A general update and a Portuguese perspective

J.C. Rufo, I. Annesi-Maesano, P. Carreiro-Martins, A. Moreira, A.C. Sousa, M.R. Pastorinho, N. Neuparth, L. Taborda-Barata

Pulmonol. 2024;30:378-89

Full text access

Share

Letters to the editor

Use of automatic 6-minute walking test recording system in patients with chronic respiratory diseases

R. Torres-Castro, H. Pascual, A. Alonso, E. Gimeno-Santos, M. Palomo, J.A. Barberà, J. Bigorra, J. Batlle, ... I. Blanco

Pulmonol. 2024;30:390-2

Full text access

Share

Is there any physiological reason to train expiratory muscles in people with mild COPD?

M. Paneroni, M. Vitacca, B. Salvi, C. Simonelli, M. Arici, N. Ambrosino

Pulmonol. 2024;30:393-6

Full text access

Share

Methicilin-susceptible Staphylococcus aureus clonal complex 398: An unusual agent of necrotizing pneumonia

C. Nobre, P. Moniz, N.A. Faria

Pulmonol. 2024;30:397-400

Full text access

Share

Association between sputum myeloperoxidase concentration and acute exacerbation of bronchiectasis

B. Yang, H. Lee, H. Yun, C. Seong, E.-G. Kim, J.‑K. Choi

Pulmonol. 2024;30:401-5

Full text access

Share

Correspondence

Regarding the prognostic factors in patients with ALK-positive non-small cell lung cancer treated with crizotinib

Limei Hu, Youjun Xie, Hongying Zhao

Pulmonol. 2024;30:406-7

Full text access

Share

Mould exposure and COPD outcomes: Association or causation?

Hiroshi Ito

Pulmonol. 2024;30:408-9

Full text access

Share

Images

Pulmonary embolism recurrence diagnosed by endobronchial ultrasound

A. Bugalho

Pulmonol. 2024;30:410-1

Full text access

Share

Pulmonology